Skip to content

Public FDA record

Z-1092-2009: GE Innova 3100 / 3100 IQ, Cardiovascular Imaging System, GE Healthcare, Waukesha, WI 53188 (The system co

Recall record Z-1092-2009 for GE Medical Systems, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1092-2009
Company in FDA record
GE Medical Systems, LLC
FDA classification date
Mar 12, 2009
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

GE Healthcare reported an issue with the Exposure Switch Redundancy system with Innova Systems 3100 & 4100, in which this error stays on, even after the pedal is released, inhibiting further x-rays, and a system reset is required to recover.

Source facts

Action
On site visits were performed from 3/6/08 - 12/19/08 to update software on all 5 units.
Initiated
2008-03-06
Root cause
Software design
Terminated
2014-09-04
Distribution
Worldwide Distribution -- USA including states of MD, TX, and VA and country of China.
Recall number
Z-1092-2009
Recall status
Terminated
CDRH record ID
78873
FDA classified
2009-03-12
Recall event number
51159

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗